Omrix suspends trial

Shortly after announcing positive data for Fibrin Pad, an experimental product for managing bleeding, Omrix said that it suspended the Phase II clinical trial "to investigate an incident of post-operative bleeding." The company says it will provide an update once additional information is available. Omrix release